Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials Shrita Patel Anne Hickman Robert Frederich Susan Johnson Susan Huyck James P. Mancuso Ira Gantz Steven G. Terra 10.6084/m9.figshare.11982252.v1 https://adisjournals.figshare.com/articles/figure/Safety_of_Ertugliflozin_in_Patients_with_Type_2_Diabetes_Mellitus_Pooled_Analysis_of_Seven_Phase_3_Randomized_Controlled_Trials/11982252 <p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> 2020-03-26 10:15:51 Ertugliflozin Genital mycotic infection Sodium-glucose cotransporter 2 inhibitor Type 2 diabetes mellitus Urinary tract infection Volume depletion